The diagnosis of Canadian superstar Celine Dion with “Stiff-Person Syndrome” has once again shone a spotlight on a rare and complex neurological disorder that can turn seemingly simple movements into a daily challenge.
The syndrome is a chronic neurological disorder that is often linked to an autoimmune mechanism. It can develop at different stages of life and is characterized by muscle stiffness and painful spasms that can suddenly worsen when triggered by factors such as loud noises, touch, or emotional stress.
Neurologist Dr. George Hanna explains that “treatment primarily focuses on controlling the symptoms, particularly spasms and stiffness, through muscle relaxants and treatments that help ease the severity of muscle contractions.”
Medications used include “diazepam (Valium) and baclofen,” along with physical therapy and other approaches prescribed according to the patient’s condition and the severity of the symptoms.
Dr. Hanna notes that the treatment currently available remains focused on managing symptoms, explaining that medicine does not treat the disease itself, but rather its manifestations.
As for future treatment options, he points out that “research may move toward gene therapy, but it is still at the research stage and is not yet available to patients.”
At the same time, Hanna explains that “having the syndrome does not necessarily mean that the patient will be unable to lead a normal life, as cases vary from one person to another.”
One of the key factors in understanding the disease is believed to be a disruption in inhibitory nerve signals, such as those associated with the neurotransmitter “GABA.”
Some patients have antibodies against the “GAD65” enzyme, while others may have antibodies against glycine receptors and “Amphiphysin.” However, the presence of an antibody alone is not enough to confirm the diagnosis, which also depends on the clinical picture, neurological examination, blood tests, electromyography, and ruling out other similar disorders.
The severity of the syndrome varies from person to person. Some patients may maintain a good degree of independence by keeping their symptoms under control, while the syndrome remains chronic and has no curative treatment to date.
Although muscle relaxants and medications that help reduce spasms are a key part of treatment, medical care does not focus solely on managing symptoms. Intravenous immunoglobulin, or “IVIG,” is used in some patients when the response to anti-spasm medications is insufficient.
Delayed Syndrome Diagnosis at Times (Pexels)
A randomized, double-blind trial led by neuroscientist Marinos Dalakas and his colleagues found improvements in stiffness, hypersensitivity, and spasms among patients who received “IVIG,” while some symptoms returned after they were switched to a placebo.
“Rituximab,” which targets B cells, has also been studied in the syndrome, but the available evidence remains insufficient to consider it a standard treatment.
The most interesting development in recent years has come from research into chimeric antigen receptor T-cell, or “CAR-T,” therapy. In advanced clinical trials, promising improvements have been reported among patients with the syndrome.
One study included 26 participants and showed a median 46% improvement in walking performance after 16 weeks, while 81% of participants achieved clinically significant improvement in their ability to walk.
However, despite these highly positive results, the findings are still relatively recent and require further follow-up and larger studies to determine the durability of the treatment’s effectiveness and its long-term safety. Research is also gradually shifting toward targeting the underlying immune dysfunction itself.
The story of Canadian superstar Celine Dion, who announced that she had the disease in December 2022 after years of suffering from vague symptoms and muscle spasms that affected her voice and ability to move, highlights the major challenges associated with this disorder.
Its symptoms can initially resemble those of other conditions, such as multiple sclerosis and Parkinson’s disease, making diagnosis a complex process that can take years and requires a careful assessment by a neurologist. This assessment relies on a clinical examination, electromyography, and tests for “GAD65” antibodies to rule out other causes. During this time, Dion devoted herself to intensive physical therapy and rehabilitation to cope with these daily challenges.
The diagnosis forced her to step away from the spotlight and live performances for many years. However, she continued her courageous fight, making a major and moving return to the stage with a series of major concerts in Paris, proving that determination can overcome even the most difficult health challenges and make a return to the stage possible.
Thank you for subscribing to our newsletter
